NCT07571551
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University Nanjing, Jiangsu, China
Clinical trial condition
Clear Cell RCC
Explore clinical trials studying Clear Cell RCC. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Clear Cell RCC trial results
Active, not recruiting
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
NCT05581004
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +57 more
- Locations
-
- Stanford University San Francisco, California, United States
- University Of Colorado Aurora, Colorado, United States
- Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
- Winship Cancer Institute Atlanta, Georgia, United States
NCT03108066
- Conditions
- Abnormalities, Multiple, Adenocarcinoma, Angiomatosis, +35 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States